Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a

Hepatitis B surface antigen (HBsAg) loss is an ideal treatment endpoint for patients with chronic hepatitis B (CHB). We investigated the predictive value of on-treatment HBsAg levels for HBsAg loss in hepatitis B e antigen (HBeAg)-negative CHB patients who received 120-week PEG-IFNα-2a treatment. Se...

Full description

Saved in:
Bibliographic Details
Published in:Virol Sin
Main Authors: Li, Minghui, Zhang, Lu, Lu, Yao, Chen, Qiqi, Lu, Huihui, Sun, Fangfang, Zeng, Zhan, Wan, Gang, Zhao, Linqing, Xie, Yao
Format: Artigo
Language:Inglês
Published: Springer Singapore 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8087759/
https://ncbi.nlm.nih.gov/pubmed/32975731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12250-020-00290-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items